Consolidated Standard of Reporting Trials Guidelines

双盲 安慰剂 心理学 选择偏差 临床试验 相关性(法律) 护理标准 医学 选择(遗传算法) 替代医学 家庭医学 精神科 外科 政治学 内科学 计算机科学 法学 病理 人工智能
作者
Ashok Kumar Jainer,O. A. Onalaja
标识
DOI:10.1176/appi.ajp.160.1.191-b
摘要

Back to table of contents Previous article Next article Letter to the EditorFull AccessConsolidated Standard of Reporting Trials GuidelinesASHOK KUMAR JAINER, M.D., M.R.C.Psych., , and O.A. ONALAJA, M.R.C.Psych., ASHOK KUMAR JAINERSearch for more papers by this author, M.D., M.R.C.Psych., Warwick, Warwickshire, U.K., and O.A. ONALAJASearch for more papers by this author, M.R.C.Psych., Walsgrave, Coventry, U.K.Published Online:1 Jan 2003https://doi.org/10.1176/appi.ajp.160.1.191-bAboutSectionsView EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: We read with great interest the article by Lorrin M. Koran, M.D., and his colleagues (1) that examined the effects of 28 weeks of double-blind placebo-controlled medication maintenance after 52 weeks of single-blind sertraline treatment.A randomized controlled trial, more than any other method, can have a powerful impact on patient care and is accepted by medicine as an objective scientific method and, if ideally performed, produces knowledge untainted by bias. However, it can be flawed in design and is not immune to bias. The relevance of such studies has been criticized on the grounds of selection bias and use of the placebo arm.Although the selection of patients is known to be a powerful factor affecting the results of clinical trials, little is known about recruitment issues. Many patients who are screened for a clinical trial are ultimately not included in the study. In this study, the authors gave an account of all the patients who dropped out but failed to provide information about how many subjects were initially assessed, how many were excluded, and the reasons for exclusion. We do not have any idea how many subjects responded to the advertisements and what was the participation rate, which has implications for generalizability and future research. In this context, the Consolidated Standard of Reporting Trials (CONSORT) guidelines state that all patients assessed for a trial should be accounted for and that the report should be accompanied by a diagram that explains what happened to all of the patients involved in the trial (2). The authors failed to follow the CONSORT guidelines in this regard.Placebo-control design raises questions of deception, the withholding of patient information, informed consent, the unblinding of such information, and the withholding of active treatment by randomly allocating trial medication. In this context, the Declaration of Helsinki demands that individual patients in a study be assured of the best proven diagnostic and therapeutic methods, even in the control group (3). This statement discards the use of a placebo group as a control group when a proven treatment exists. In this study, one group of patients received no treatment (placebo) for more than 28 weeks when there were a number of control group options that could have fulfilled ethical and scientific needs.References1. Koran LM, Hackett E, Rubin A, Volkow R, Robinson D: Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Am J Psychiatry 2002; 159:88-95Link, Google Scholar2. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276:637-639Crossref, Medline, Google Scholar3. Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 1994; 331:394-398Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited ByProspective Multicenter Randomized Controlled Trial Comparing Early Protected Movement and Splinting for Fifth Metacarpal Neck Fracture17 May 2021 | Plastic Surgery, Vol. 30, No. 1Respiratory Research, Vol. 19, No. 1 Volume 160Issue 1 January 2003Pages 191-b-192 Metrics History Published online 1 January 2003 Published in print 1 January 2003

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
彭于晏的应助被缺粥采纳,获得10
4秒前
4秒前
4秒前
cici完成签到,获得积分10
5秒前
5秒前
羊腿完成签到 ,获得积分10
6秒前
TGJ发布了新的文献求助10
6秒前
慕青的应助被ssswww采纳,获得10
6秒前
1210xi完成签到,获得积分10
7秒前
世间安得双全法完成签到,获得积分0
8秒前
Maestro_S完成签到,获得积分0
8秒前
8秒前
8秒前
weqhdgjfk完成签到,获得积分10
8秒前
无头苍蝇完成签到,获得积分10
8秒前
躺平青年阿俊完成签到,获得积分10
8秒前
9秒前
st完成签到,获得积分10
9秒前
jzhou65完成签到,获得积分10
10秒前
10秒前
sense发布了新的文献求助10
11秒前
花花完成签到,获得积分10
11秒前
11秒前
11秒前
CC66发布了新的文献求助10
12秒前
12秒前
捞鱼完成签到,获得积分10
13秒前
13秒前
13秒前
ssswww完成签到,获得积分10
13秒前
张志辉完成签到,获得积分10
13秒前
薛小飞发布了新的文献求助10
14秒前
dent强完成签到,获得积分10
14秒前
无限紫槐发布了新的文献求助10
15秒前
ddd发布了新的文献求助10
15秒前
古语发布了新的文献求助10
15秒前
66发布了新的文献求助10
16秒前
烟花的应助被cxy采纳,获得10
16秒前
Shirly完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054